Abstract-Center of pressure ͑COP͒ traces have been used to investigate the dynamics of human balance. In this paper we employ a wavelet-based multifractal methodology to identify structural differences in mediolateral and anterioposterior sway between COP traces of healthy and Parkinson's patients. Two statistical techniques are used to summarize the differences in multifractal spectrum ͑MFS͒ for both groups. The first technique is a multivariate repeated measures analysis on estimated MF spectra for subjects. The second technique obtains two characteristic measures from each subject's estimated MFS: ͑i͒ location and ͑ii͒ half-width of the spectrum. These measures present an intuitive summary of the MFS for each subject, allowing for statistical comparisons between the two groups. Both analyzes lead to significant discrimination between Parkinson versus healthy subject's MFS. We find that COP time series of Parkinson patients exhibit a greater degree of roughness as compared to healthy subjects' COP traces. Furthermore, MFS for Parkinson patients are narrower, suggesting a reduction in complexity as compared to the healthy group. The methodology presented here may be helpful in development of clinically relevant measures, including the assessment of severity of conditions as the measures developed here correlate with standard severity measures.
INTRODUCTION
Outputs of the human postural control system under erect stance are often very irregular. For instance, centerof-pressure ͑COP͒ trajectories of subjects under erect stance are very erratic. Despite the irregular behavior of COP trajectories, they have been used as the basis to characterize quantitatively some of the motor impairments associated with idiopathic Parkinson's disease ͑PD͒. 11 In this paper we implement a methodology to further gain insight into the differences in COP trajectories between PD and healthy subjects. While this methodology is applied to COP data in this paper, it is in fact a procedure applicable more generally to time series data.
Recently, researchers have identified interesting properties of COP traces pertaining to their degree of smoothness and correlation structure. They have studied these properties as they relate to the dynamics of the human postural control system and its pathologies. In particular, they have identified long-range dependence, scaling behavior, and fractal-like properties in COP traces. 3, 7, 11, 15 Collins et al. first identified long-range dependence in COP traces and computed their Hurst parameter, a measure of both roughness and correlation in a time series. 4 Other researchers have investigated the likeness of COP displacements to 1/f noises, and proposed to estimate the fractal dimension of the traces in order to assess their degree of roughness. 3, 7 More recently, wavelet-based techniques have been used to estimate the possibly multiple scaling behavior present in these signals. In particular, Thurner et al. conclude, using wavelet-variance estimation techniques, that COP traces are a correlated process that presents different scaling regions, suggesting the presence of a multifractal structure. 15 In this paper, we investigate the multifractal nature of COP traces and develop statistical procedures based on the wavelet transform in order to link the classical notion of the multifractal spectrum ͑MFS͒ to measures of potential use in the study of the human postural control system. More precisely, we implement a methodology to further gain insight into the differences in COP trajectories between idiopathic Parkinson's disease patients and otherwise healthy individuals.
As a motivation, consider the two COP trajectories depicted in Fig. 1 . The top trajectory is the mediolateral ͑ML͒ output for a healthy subject, while the bottom trajectory corresponds to a ML output from a Parkinson patient ͑the experimental details will be given in the Methods section͒. A striking difference between the two trajectories lies in their smoothness. The top COP output seems to the eye to be a much smoother curve than the bottom one, although its smoothness may not be altogether homogeneous. This characteristic distinction may serve as the basis for a discriminating measure between PD and healthy subjects. In order to construct such a discriminating measure, we are in need of tools that quantify degrees of smoothness in curves. An increasingly popular measure of a signal's degree of smoothness is the so-called multifractal spectrum.
The multifractal spectrum of a signal or process summarizes the scaling behavior and quantifies the relative degree of regularity present in it.
14 Processes for which the MFS exhibits evidence of potentially intricate, locally varying regularity are termed multifractal. These processes are increasingly being used as successful modeling tools in a wide variety of fields including medicine and biology. 6, 8, 12 The multifractal spectrum consists of two quantities. The first quantity measures the degree of regularity or smoothness of a time series, while the second quantity identifies the prevalence of each degree of regularity present in such a process. Formally, one first defines a measure of local smoothness, say ␣, often based on local scaling properties, and then a set function f (␣) that measures the prevalence of the smoothness ␣ in the signal.
A typical MFS for a multifractal signal is shown in Fig. 2 . Notice that the MFS of a multifractal signal is generally a convex curve. The most prevalent smooth behavior is ␣ 0 , and the range of smoothness is given by the quantities (␣ min ,␣ max ). In contrast to a multifractal signal, a monofractal signal exhibits a unique smooth behavior ␣ 0 ; that is, the MFS of a monofractal signal collapses to a single point mass at ␣ 0 ϭ␣ min ϭ␣ max .
In general, the MFS of a signal provides ͑i͒ a measure of the signal's prevalent degree of smoothness as given by the MFS location ͑i.e., the value of ␣ 0 ͒ and ͑ii͒ a measure of the signal's departure from monofractality as given by the spread of the values ␣ min and ␣ max . Information about differences in smoothness between two signals can be obtained by studying both the location and spread of their respective MF spectra.
In this paper, we will study how estimates of both location and spread of the multifractal spectrum of COP traces may lead to discriminating measures between PD patients and healthy subjects. For instance, a difference in location would indicate that generally COP traces are smoother in one group as compared to COP traces of the other group. A difference in spread in their respective multifractal spectra would suggest a restricted range of smoothness of the COP traces of one group with respect to the other group.
It is of paramount importance that tools for the analysis of multifractal processes are adapted to cope with these processes' potential nonstationarity, and timevarying statistical properties. To this effect, analytic tools for MFS estimation should preserve local features of the analyzed signal.
Wavelet transforms ͑WT͒ are well-suited to the study of local scaling behavior and regularity of multifractal processes, since a WT is localized in time and preserves the scaling properties of a given signal. Recently, a number of wavelet-based techniques for estimating a MFS have been introduced by various investigators. 1, 9, 16 In this paper, we use an estimator based on the discrete wavelet transform, which is analogous to an estimator based on the continuous wavelet transform in Arneodo et al. 1 One of the main aims in this work is to develop measures that can potentially be used to discriminate between typical COP trajectories from healthy subjects and COP trajectories from subjects with balance pathologies such as those often associated with a disease like idiopathic Parkinson. We propose in this work statistical models based on MFS estimation that may serve as the basis for identifying human balance pathologies.
More generally, the techniques developed in this paper can be the basis for tools to investigate and detect pathological patterns in biological data for cases where: ͑a͒ the biomedical output under study is a time series, and ͑b͒ the presence of the pathological condition manifest itself through a patterned modification of the smoothness of the time series ͑as compared to the nonpathological base case͒. Furthermore, the techniques presented here provide the investigator with reliable and fast procedures leading to interpretable measures.
THEORY
We start with a brief description of the DWT and its properties. Let j,k (t)ϭ2 j (2 j tϪk), where (•) is a wavelet function with compact support and N vanishing moments. 5 Given a process x(t), the wavelet coefficients of the process are defined as
for all integer pairs ( j,k). Notice that for large positive j, W j,k contains information in x(t) corresponding to small scales and high frequency; for large negative j, the information pertains to coarse scales and low frequencies. Our interest in this paper will be in the estimation of the fractal spectrum of a time series, based on the wavelet coefficients ͕W j,k ͖ of a sample.
A key feature of the wavelet transform is that local smoothness of a signal can be estimated by studying the decay of the wavelet coefficients. In particular, a measure of local regularity may be defined as
where k2
The quantity ␣(t 0 ) is a measure of the smoothness of x(t) around the time t 0 .
Multifractal processes exhibit such an intricate pattern of locally varying regularity that estimates based on properties such as Eq. ͑2͒ alone are often not reliable. In order to overcome this difficulty, the so-called multifractal formalism ͑MFF͒ was introduced. The MFF is a method by virtue of which both the local regularity and the MFS of a signal can be computed, using a structure function relating the two.
The structure function is chosen so as to characterize the scaling of the statistical moments of the wavelet coefficients W j,k . Specifically, for any qR, and jу0 the structure function is defined as (q)ϭlim j→ϱ (q, j) Ϫ1, where
and E͓•͔ denotes statistical expectation. Note that in practice, Eq. ͑3͒ can be estimated by the qth sample moment
where N is the largest power of 2 less than the length of the data set. Under some technical conditions, including the convexity of the function (q, j) in q, the MFF states that the structure function (q) relates the local regularity of the signal and the MFS via the Legendre transform
where the minimum is attained at the value of q for which (d/dq) (q)ϭ␣. In this way, one can relate the MFS f (␣) with the local regularity ␣ via a parameter q. In particular we can define ␣(q) ϭlim j→ϱ (d/dq) (q, j), and note that convexity of (q) yields that ␣(q)Ͼ0.
14 Based on the MFF, for a range of moments q (q 1 ,q 2 ) a scale dependent estimator of the local regularity can be defined as
and the limiting behavior of ␣(q, j) can be obtained via a linear regression over a range of scales ( j 1 , j 2 ):
where
and  is the average scale. Observe that the estimator ␣ (q, j) is a sample-based version of the exact derivative with respect to q of the partition function (q, j) in Eq.
͑3͒. An estimate of the MFS can then be obtained by
Using wavelet library functions in standard packages such as Matlab, the earlier procedure can be easily implemented. It is also worth noting that due to the existence of fast algorithms for the wavelet transform, all the computations required can be implemented very efficiently. In addition, wavelet-based methods yield generally improved estimation of the MFS of signals. 1 In what follows, we will develop a procedure to test for significant differences in MFS of COP trajectories of healthy subjects and idiopathic Parkinson's patients.
METHODS
The data for our analysis were gathered in a series of experiments performed by researchers at the Boston University Department of Biomedical Engineering. In the experiments, a Kistler 9287 force platform was used to record the ML and anterioposterior ͑AP͒ displacements of the COP under the feet of the subjects.
COP measurements were taken from 25 subjects, 10 healthy and 15 Parkinson's patient. A series of ten 60 s trials was conducted for each PD and ten 90 s trials for healthy subjects at a sampling frequency rate of 100 Hz. To avoid disparity in the lengths of the time series, only the first 2 12 data points of the times series were analyzed for all subjects. The experimental output to be analyzed consists then of twenty 2 12 long time series per subject: ten univariate series containing ML displacement data, and ten univariate series containing AP sway output.
To motivate the statistical procedures that will be introduced later, we will first apply the wavelet-based MFS estimation method explained in the previous section to the individual series, and obtain useful descriptive summaries. In particular, for a grid of values qϭ͕Ϫ1, Ϫ0.95,...,2͖, we use a fixed range of scales ( j 1 ϭ5,j 2 ϭ11) to perform the linear regressions in Eqs. ͑6͒ and ͑8͒. Figure 3 depicts the MFS of ML COP trajectory of a healthy subject. The convex shape of the MFS is consistent with evidence of multifractality. A common practice to summarize the difference in MFS in signals from two groups is to plot the group's respective averaged spectrums. Figure 4 shows the averaged MFS over all trials for the PD and healthy subjects. Notice that the PD averaged spectrum is to the left of the averaged spectrum for healthy subjects. This fact suggests that, on the average, COP trajectories of Parkinson's patients exhibit a lower degree of smoothness as compared to healthy subjects' trajectories. A similar pattern is observed for the averaged spectrum of the AP sway.
The averaged spectra in Fig. 4 seem to differ not only in location but also in their respective spreads ͑or curvature͒. In particular, the averaged MFS for PD seems narrower than the MFS of healthy subjects, suggesting that COP trajectories of healthy subjects have a wider range of smoothness, while COP trajectories of Parkinson's patients exhibit a reduced range in regularity. In other words, COP trajectories of healthy subjects seem to present a higher degree of multifractality.
While the averaged MFS indicates a marked difference between the two groups ͑in location and possibly spread͒, we would like to know if such difference is significant in a statistical sense. To answer this question we propose two complimentary methodologies. The first FIGURE 3. Estimated MFS of mediolateral COP traces for a healthy patient. The figure displays the averaged spectrum over ten trials using a Daubechies wavelet with three vanishing moments and a grid of sample moments qÄˆÀ1, À0.95,...,2‰. We used scales "j 1 ,j 2 …Ä"5,11… for the regression based estimates of both ␣"q… and f †␣"q… ‡. method is based on a multivariate repeated measures analysis of samples of the estimated spectrum for each subject, and the second is based on a multivariate analysis of variance ͑MANOVA͒ of estimated quantities pertaining to both location and spread of the COP multifractal spectrum.
For both analysis we assume that the degree of smoothness of both the ML and AP sway of each subject can be summarized by an idealized MFS. This idealized spectrum is to be estimated by repeated samples from the subject's COP trajectories. Since in practice we only have access to a discrete number of moments q when performing MFS estimation the output of the waveletbased procedure explained above can be viewed as a discretized estimate of the MFS.
A Multivariate Repeated Measures Model
First observe that the setup of the experiment where data on the COP trajectories were obtained corresponds to a so-called repeated measures design where subject's COP trajectories are observed over ten trials. While we could compute estimates for ␣(q) and f ͓␣(q)͔ on a grid of q's as fine as we desire, sample size considerations lead us to use only a small number of the q's. In particular we will use only five q's, namely, qϭ͕Ϫ1, Ϫ0.5,0,0.5,1͖. From each subject, we obtain ten estimates of the spectrum; that is, ␣(q) and f ͓␣(q)͔ are estimated for each trial on ML and AP COP trajectories separately for each given q. Each trial yields a sampled spectrum of points ͕␣ (q m ), f ͓␣(q m )͔͖ for mϭ1,...,5.
Hence, each trial leads to five bivariate observations. In order to keep the ratio of number of dependent variables to total sample size small, we model exclusively the sampled ␣(q)'s. In summary, the data to analyze comprises a set of five observations per trial per subject, and since we do not assume that observations across trials are independent, the design of the data to be analyzed corresponds to a multivariate repeated measures ͑MRM͒ on the observed ␣ (q)'s.
In accordance to standard practice for MRM data, the model we assume is Model 1 We assume that the variancecovariance matrix is a block diagonal matrix where each block corresponds to each subject's variance-covariance matrix for the multivariate observations across trials. We only assume independence between subjects, and allow for heterogeneity of variances of observations across trials, and do not assume that the variances are the same in the two groups. In summary, the MRM model presented here is a multivariate normal model where we have allowed for heterogeneity of variances across subjects and groups.
In order to motivate the usefulness of this model, we enumerate the following interpretations for the test of some of the parameters in the model. Testing that the Group i effect is statistically significant addresses the issue that the estimated ␣ i, j,k,m,l 's for the healthy subjects are on the average different from the corresponding es-timates for the Parkinson's patients. That is, a significant group effect means that after taking into account other effects such as subject and trial, the two groups are different in terms of their multifractal spectra. A significant Q m effect would indicate that there is a difference between the estimated ␣(q m )'s when q m varies. This fact would result in evidence of multifractality of the original signal since a monofractal signal would yield that the ␣(q m )'s attain the same values for all m's ͓i.e., ␣(Ϫ1)ϭ¯ϭ␣(0)ϭ¯ϭ␣(1)͔. The Group * Q im interaction has the following important interpretation: if the Group * Q im interaction is significant, this would be an indication that the way the ␣(q)'s are spread around ␣(0) is different in each group, suggesting a different degree of multifractality for each group.
While the MRM model just explained deals exclusively with the estimated ␣(q)'s, it is important to note that the statistical results will yield information about the whole spectrum. Particularly, differences in ␣͑0͒ between the groups would indicate a difference in the location of the spectrum. Furthermore, both the Q m effect and the Group * Q im interaction yield information about the spread of the spectrum, which translates into a measurement to possibly distinguish between monofractality and multifractality.
In addition to identifying differences in multifractal spectra for typical COP trajectories in both groups of the study in terms of location and spread, it would be useful to consider the curvature of the spectra and inquire if differences are also found in this respect. To obtain a measure of the curvature of the estimated spectra for subjects in both groups we need to introduce the estimated values of f ͓␣(q)͔ into the analysis. We do so in the following model.
Location and Half-Width of the MFS
In order to investigate the curvature of the MFS of a signal from its estimate, we propose to measure the lefthand, half-width of the MFS at a prespecified height. Note that under the underlying assumptions for the existence of a spectrum, we obtain that the MFS is a unimodal, convex curve with support on the positive real numbers. Hence, the left-hand, half-width of the spectrum is a well defined quantity. Observe that under the aforementioned assumptions, we have that and ␣ 0 , suggesting the presence of a more monofractal signal than one exhibiting a larger value for its corresponding spectrum d-level half-width. Hence, the quantity HW(d) computed from the MFS of a signal is interpretable as the degree of multifractality of such signal. In practice, it has been widely reported that the right-hand side of the spectrum is particularly elusive. 2 We propose to concentrate efforts on the half part of the spectrum which is more amenable to stable estimation.
It is important to emphasize that the values ␣ 0,s(i) , and HW(d) s(i) estimate the two most prominent features of the subjects' MFS: location and spread/curvature. The former measuring the prevalent smoothness of the signal, and the latter serving as a measure of departure from this prevalent behavior.
For each subject, we obtain the estimate where ␣ 0 ,HW(d) is a grand mean for the bivariate output under consideration, Group i is the group effect, and ⑀ s is a mean zero bivariate normal random vector. Notice that a significant group effect would indicate that both groups differ in their respective multifractal spectrum with respect to both location and d-level half-width.
Observe that the quantity HW(d) depends on the level d; hence, it is pertinent to study the sensitivity to the choice of level d to use for a given analysis.
An important aspect of this last model is that it leads to estimates on both location and curvature which are readily interpretable.
RESULTS

Analysis of Results from Model 1
In order to fit the MRM model suggested in the previous section, we used a maximum likelihood estimation procedure called PROC MIX available in the software package SAS for mixed linear models. This procedure allows to test for significance even under heterogeneity of variances. For the statistical test performed, robustness to departure from the normality assumption depends on sample size considerations. 10 In order to preserve the validity of the statistical tests, we keep the ratio of the smallest group to the number of trials high ͑a ratio of at least 3 is recommended͒. 10 That is, since we have only ten subjects in the healthy group, we use data from at most three trials ͑i.e., tϭ1,2,3͒.
Conforming to standard practice, we perform an approximate F test to investigate the significance of the fixed effects in the model. Table 1 displays the result of the approximate F tests for the fixed effects of the model applied to the AP data. Notice that Group i , Q m , and the interaction GROUP * Q im are highly significant. This finding suggests that there is evidence to conclude that COP trajectories for the two groups differ in terms of their respective estimated degrees of smoothness ␣(q m ). Furthermore, for the two groups, the evidence suggests that the COP trajectories' MF spectra are consistent with multifractal behavior. Table 2 displays the results of the approximate F tests for the analysis of ML output, which yields similar results to that of the AP sway.
Analysis of Results from Model 2
In order to implement the second model described in the Methods section, we first compute from the data the values corresponding to ␣ 0 , and HW(d), which are the values for location and half-width of the estimated MF spectra.
To estimate ␣ 0 for each subject we take the average value of ␣ for which f (␣)ϭ1 over all the trials. In order to compute the d-level half-width, it is necessary to first choose the level 0рdϽ1. We chose dϭ0.95, and then performed sensitivity analysis to this choice, finding that the test results from the MANOVA did not lead to different conclusions as d was changed from 0.90 to 0.98. In order to obtain an estimate for ␣ * from the estimated multifractal spectra for each subject, we need to solve the following inverse problem: find the value of ␣ for which f (␣)ϭ0.95. Since the estimated MFS is a discrete sample, there is no guarantee that there will be a value in the sample that exactly attains the f (␣) value of 0.95. However, we can compute as many moments q as desired in order to achieve some tolerance level. Alternatively, one may interpolate between sampled values of the average MFS using standard spline algorithms. In any case, we take ␣ * to be the value of ␣ at which f (␣) is approximately equal to 0.95 to within a tolerance level. Figure 5 exemplifies the procedure to estimate both location and half-width. The figure displays the average MFS for a PD patient over all ten trials. The estimate of ␣ 0 is the ␣ value where the curve f (␣) attains the value of 1, and the HW(0.95) is the horizontal distance between ␣ 0 and the ␣ at which the curve attains the value of 0.95 ͑to within a tolerance value of 0.001͒.
The bivariate quantity ͓␣ 0,s(i) ,HW (d) s(i) ͔ is then used to compare the two groups in terms of their possible difference in multifractal spectra. Such difference, as it was stated before, is quantified by the joint differences in location and curvature. To visually inspect the difference in both location and curvature exhibited by the MFS of the two groups in consideration, Figure 6 presents a bivariate plot of location and curvature of the MFS for the two groups. Observe that there is a clear separation between the two groups in terms of location and half-width, except for an obvious outlier. Note that a narrower MFS would indicate a less complex signal. This can be interpreted as COP traces of PD patients exhibiting less complexity than COP traces of healthy subjects.
These two graphs provide a simple, interpretable, and visual summary of the fact that PD patients exhibit COP traces which are: ͑i͒ less smooth than COP traces of healthy patients, and ͑ii͒ exhibit a reduced range in degrees of smoothness as compared to healthy COP traces. That COP traces for PD patients are rougher in nature as compared to healthy COP traces is indicated by the estimated regularity parameter ␣ 0 , which represents the location of the MFS. Lower values of ␣ indicates a more erratic behavior of COP traces. The half-width of the MFS represents the degree of multifractality, or in other words, how homogeneous the COP trace is in terms of smoothness.
Using SAS to perform a MANOVA on location and half-width for subjects in the two groups we obtain p values less than 0.0001 for each AP and ML sway for all MANOVA standard statistics such as Wilk's Lambda, Pillai's trace, and Roy's greatest root. This indicates significant differences in the two groups with respect to their MF spectra in terms of location and half-width.
Estimated least squares ͑LS͒ means for the AP and ML sway of both groups are displayed in Tables 3 and 4 , as well as the estimated contrast ͑or difference͒ in terms of ␣ 0 and MFS half-width for the two groups.
Multifractal Spectra and Measures of Disease Severity
In light of the earlier results, it is important to know how the measures ␣(0) and the HW(d) correlate with standard measures of severity of balance impairment. Recent development of measures of muscle stiffness from COP traces reveal that roughness of trajectories are correlated to the severity of impairment in the human postural control system. Lauk et al. 11 observe that roughness of AP traces correlates to measures of rigidity, bradykinesia, posture impairment, and others. As indicated in Fig. 1 of the cited work, the severity of the Tables 5 and 6 show the correlation measure for a diverse subset of clinical scales of human balance with the multifractal spectrum location parameter ␣(0) and HW(0.95) for both the AP and the ML traces. Observe that in the AP direction, the location parameter ␣(0) correlates with the clinical measures in the table, except for arm. For the ML direction, all clinical measures correlate with the location parameter. The half-width of the estimated spectrum correlates with all clinical measures in the AP direction except again for arm. No distinct trend emerges in the correlation of clinical measures and the estimated half-width for the spectra of ML traces, except that the clinical measure arm seems to correlate well with both the half-width and location parameter in both the AP and ML directions. An intriguing fact arises at this point, and it would be interesting to investigate further why both the degree of roughness ͓i.e., ␣(0)͔ and the degree of multifractality ͓i.e., HW(0.95)͔ correlate well with the clinical measure arm in the ML direction and not in the AP direction. An investigation in this respect may reveal a difference in the postural control system dynamics for each direction.
DISCUSSION
Using a wavelet-based procedure to estimate the MFS of COP traces from healthy subjects and PD patients, we determined that there is a significant difference in such traces for the two groups in terms of their corresponding degrees of smoothness. We have presented two complimentary statistical procedures to address the issue of comparing multifractal spectra of subjects with a balance impairing disease such as Parkinson's disease to multifractal spectra of COP traces of otherwise healthy subjects. We find via the first procedure, a multivariate repeated measures analysis, that the multifractal spectrum of COP traces for Parkinson patients is statistically different from the MFS of healthy subjects in terms of location and spread. It was also found that the MFS for both groups ͑and in both AP and ML sway͒ suggests that COP traces exhibit multifractal behavior. The second procedure, a MANOVA on bivariate estimates of location and half-width of the MFS, suggest that the multifractal spectra of both groups differ not only in location, but also in curvature, as measured by the half-width of the spectrum. Since location and curvature are two defining characteristics of a MFS, we can confidently claim that both groups differ in terms of their estimated multifractal spectra. As it can be observed in Figs. 6 and 7, location and spread of the multifractal spectra of COP traces serve as good discriminating measures between PD patients and healthy subjects.
The fact that both the location and the spread of the MFS of COP traces also correlate with standard measures of disease severity in PD patients suggests that they may be potentially useful as objective measures of severity.
Given ͑i͒ the reliable methodology based on the wavelet transform presented in this paper ͑among others available͒, ͑ii͒ the efficiency of the algorithms used, and ͑iii͒ the potentially useful measures derived, further study seems appropriate to assess the impact of these methods in areas pertaining to identification and diagnosis of balance pathologies.
On a more general note, the methodology developed here can be applied to other biomedical output and signals in the form of time series, with the potential of being similarly successful in identifying and discriminating different degrees of smoothness in signals.
